These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35784107)

  • 1. The Mystery of Mucormycosis in COVID-19: A Multifactorial Menace or an Enigmatic Delta Variant Associated Phenomenon? An Exploratory Study from a Tertiary Care Centre in North India with a Brief Literature Review.
    Kalita D; Bhatia M; Rekha US; Singh A
    J Pharm Bioallied Sci; 2022; 14(1):46-51. PubMed ID: 35784107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
    Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
    Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycosis and COVID-19 an epidemic in a pandemic?
    Banerjee I; Robinson J; Asim M; Sathian B; Banerjee I
    Nepal J Epidemiol; 2021 Jun; 11(2):1034-1039. PubMed ID: 34290893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
    Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
    Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.
    Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ
    Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
    Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
    Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Profile of Mucormycosis Patients during Coronavirus Disease 2019 Pandemic: A Retrospective Observational Study.
    Gondane B; Jain SK; Dube S
    J Assoc Physicians India; 2024 Mar; 72(3):27-31. PubMed ID: 38736113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Observational Study of Fungal Infections in COVID-19: Highlighting the Role of Mucormycosis in Tertiary Healthcare Settings.
    Singh R; Mittal G; Kakati B; Koul N
    Cureus; 2024 Mar; 16(3):e57295. PubMed ID: 38690487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Second COVID-19 Wave Is a Tsunami With Aftershocks: Mucormycosis Ire as Seen in a Tertiary Care Hospital in Uttarakhand, India.
    Raina D; Rohilla R; Patwal S; Pandita A
    Cureus; 2023 Oct; 15(10):e47358. PubMed ID: 38021725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.
    Rao VUS; Arakeri G; Madikeri G; Shah A; Oeppen RS; Brennan PA
    Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1095-1098. PubMed ID: 34507870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing trend of fungal infection in invasive rhinosinusitis in the COVID era.
    Garg P; Ranjan V; Avnisha ; Hembrom S; Goel S; Malhotra S
    J Family Med Prim Care; 2024 Apr; 13(4):1428-1433. PubMed ID: 38827671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five probable factors responsible for the COVID-associated mucormycosis outbreak in India.
    Ravindra K; Ahlawat A
    Int J Infect Dis; 2021 Nov; 112():278-280. PubMed ID: 34592439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological association of mucormycosis in COVID 19 pandemic.
    Varshney M; Saxena A; Binnani N; Kumar V; Vyas SP
    Indian J Pathol Microbiol; 2023; 66(1):101-105. PubMed ID: 36656219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucormycosis and Covid-19 : Risk Factors, Clinical Presentation and Outcome in a Tertiary Care Centre in North India.
    A GA; Ashraf H; HaiderMehdi HS
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
    Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
    J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID19 associated mucormycosis: Is GRP78 a possible link?
    Gumashta J; Gumashta R
    J Infect Public Health; 2021 Oct; 14(10):1351-1357. PubMed ID: 34538732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical appraisal of mucormycosis in COVID- 19 patients in a tertiary care centre in India.
    Raychaudhuri S; Taneja J; Sasidharan J; Pujani M; Singh K; Chatterjee T; Jain M; Chandoke R; Rai A; Abbas Z; Das A
    Curr Med Mycol; 2023 Mar; 9(1):1-7. PubMed ID: 37867588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.
    Menia R; Raychaudhuri S; Agarwal C; Taneja J
    Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic.
    Kumar S; Choudhary R; Pandey VP
    J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.